Obesity and restless legs syndrome in men and women
Abstract
Background: Obesity and restless legs syndrome (RLS) are both associated with hypofunction of dopamine in the CNS. We therefore examined whether individuals who are obese have an increased risk of RLS in two ongoing US cohorts, the Nurses’ Health Study II and the Health Professional Follow-up Study.
Methods: We included 65,554 women and 23,119 men free of diabetes, arthritis, and pregnancy in the current analyses. Information on RLS was assessed using a set of standardized questions. Participants were considered to have RLS if they met four RLS diagnostic criteria recommended by the International RLS Study Group and had restless legs ≥5 times/month. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed using logistic regression models adjusting for age, smoking, use of antidepressant, phobic anxiety score, and other covariates. Log ORs from the two cohorts were pooled by a fixed-effects model.
Results: There were 6.4% of women and 4.1% of men who were considered to have RLS. Multivariate adjusted ORs for RLS were 1.42 (95% CI: 1.3, 1.6; p trend <0.0001) for participants with body mass index (BMI) >30 vs <23 kg/m2 and 1.60 (95% CI: 1.5, 1.8; p trend <0.0001) for highest vs lowest waist circumference quintiles. Greater BMI in early adulthood (age 18–21 years) and weight gain were also associated with a higher prevalence of RLS (p trend <0.01 for both).
Conclusions: Both overall and abdominal adiposity are associated with increased likelihoods of having restless legs syndrome (RLS). Further prospective studies are warranted to clarify causative association between obesity and risk of developing RLS.
BMI = body mass index; CI = confidence interval; HPFS = Health Professionals Follow-up Study; NHS II = Nurses’ Health Study II; OR = odds ratios; RLS = restless legs syndrome.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
REFERENCES
1.
Garcia-Borreguero D, Odin P, Schwarz C. Restless legs syndrome: an overview of the current understanding and management. Acta Neurol Scand 2004;109:303–317.
2.
Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med 2007;120:S4–S12.
3.
Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008;70:35–42.
4.
Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study: memory and morbidity in Augsburg elderly. Neurology 2000;54:1064–1068.
5.
Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006;129:76–80.
6.
Lopes LA, Lins C, de M, et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 2005;28:2633–2636.
7.
Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137–2141.
8.
Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286–1292.
9.
Allen RP. Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. Am J Med 2007;120:S13–21.
10.
Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006;5:878–886.
11.
Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001;357:354–357.
12.
Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547–554.
13.
Kim J, Choi C, Shin K, et al. Prevalence of restless legs syndrome and associated factors in the Korean adult population: the Korean Health and Genome Study. Psychiatry Clin Neurosci 2005;59:350–353.
14.
Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004;75:226–230.
15.
Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990;1:466–473.
16.
Stunkard AJ, Sorensen T, Schulsinger F. Use of the Danish Adoption Register for the study of obesity and thinness. Res Publ Assoc Res Nerv Ment Dis 1983;60:115–120.
17.
Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson’s disease. Mov Disord 2003;18:646–651.
18.
Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 1993;4:218–228.
19.
Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003;61:1562–1569.
20.
Rajaram SS, Shanahan J, Ash C, Walters AS, Weisfogel G. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS. Sleep Med 2005;6:101–106.
21.
Hamdi A, Porter J, Prasad C. Decreased striatal D2 dopamine receptors in obese Zucker rats: changes during aging. Brain Res 1992;589:338–340.
22.
Huang XF, Zavitsanou K, Huang X, et al. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav Brain Res 2006;175:415–419.
23.
Need AC, Ahmadi KR, Spector TD, Goldstein DB. Obesity is associated with genetic variants that alter dopamine availability. Ann Hum Genet 2006;70:293–303.
24.
Abbott RD, Ross GW, White LR, et al. Midlife adiposity and the future risk of Parkinson’s disease. Neurology 2002;59:1051–1057.
25.
Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, Tuomilehto J. Body mass index and the risk of Parkinson disease. Neurology 2006;67:1955–1959.
26.
Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Willett WC, Ascherio A. Obesity and the risk of Parkinson’s disease. Am J Epidemiol 2004;159:547–555.
27.
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101–119.
28.
Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007;39:1000–1006.
29.
Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007;357:639–647.
30.
Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52–57.
Information & Authors
Information
Published In
Copyright
© 2009.
Publication History
Published online: April 6, 2009
Published in print: April 7, 2009
Notes
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Spectrum of Restless Leg Syndrome from a Tertiary Care Hospital in Eastern India, Bengal Physician Journal, 11, 2, (73-75), (2024).https://doi.org/10.5005/jp-journals-10070-8051
- Sex and Sleep Disruption as Contributing Factors in Alzheimer’s Disease, Journal of Alzheimer's Disease, 97, 1, (31-74), (2024).https://doi.org/10.3233/JAD-230527
- Prevalence of restless legs syndrome during pregnancy and postpartum period, Journal of Perinatal Medicine, 52, 8, (852-857), (2024).https://doi.org/10.1515/jpm-2024-0208
- Effect of dairy products fortified with vitamin d3 on restless legs syndrome in women with premenstrual syndrome, abdominal obesity and vitamin d deficiency: a pilot study, BMC Women's Health, 24, 1, (2024).https://doi.org/10.1186/s12905-024-03159-z
- Relationship of Suboptimal and Disordered Sleep with Cardiovascular Disease and Its Risk Factors – A Narrative Review, Neuroepidemiology, (1-17), (2024).https://doi.org/10.1159/000539369
- Prevalence of restless legs syndrome in maintenance hemodialysis patients: A systematic review and meta-analysis, Sleep Medicine, 114, (15-23), (2024).https://doi.org/10.1016/j.sleep.2023.11.1138
- Analyzing the Effects of Transcutaneous Electrical Nerve Stimulation on Individuals with Restless Legs Syndrome, Sleep and Vigilance, (2024).https://doi.org/10.1007/s41782-024-00284-5
- The prevalence of and risk factors for restless legs syndrome: A nationwide study, Frontiers in Psychiatry, 13, (2023).https://doi.org/10.3389/fpsyt.2022.987689
- Restless leg syndrome and risk of all-cause dementia: a nationwide retrospective cohort study, Alzheimer's Research & Therapy, 15, 1, (2023).https://doi.org/10.1186/s13195-023-01191-z
- Worldwide estimation of restless legs syndrome: a systematic review and meta‐analysis of prevalence in the general adult population, Journal of Sleep Research, 32, 3, (2023).https://doi.org/10.1111/jsr.13783
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.